Regeneron (REGN) Q2 Earnings Top Estimates, Eylea Sales Solid
...
Regeneron reported earnings of $6.02 per share in the second quarter, beating the Zacks Consensus Estimate of $5.42. The top line also increased from $5.45 in the year-ago quarter.
Total revenues in the reported quarter increased 20% year over year to $1.93 billion and comfortably beat the Zacks Consensus Estimate of $1.80 billion. The year-over-year growth was driven by strong Eylea and Dupixent sales.
...
https://finance.yahoo.com/news/regeneron...05493.html
...
Regeneron reported earnings of $6.02 per share in the second quarter, beating the Zacks Consensus Estimate of $5.42. The top line also increased from $5.45 in the year-ago quarter.
Total revenues in the reported quarter increased 20% year over year to $1.93 billion and comfortably beat the Zacks Consensus Estimate of $1.80 billion. The year-over-year growth was driven by strong Eylea and Dupixent sales.
...
https://finance.yahoo.com/news/regeneron...05493.html
![[Bild: REGNc1dl1546.png]](https://finviz.com/publish/080619/REGNc1dl1546.png)
__________________